2017 Malaria Gordon Research Conference & Gordon Research Seminar

项目总结/摘要 2017年疟疾戈登研究会议和戈登研究研讨会 蚊子传播的疟原虫寄生虫造成了大约2亿例 全球每年有40万人死于疟疾，其中绝大多数是由疟原虫引起的。 恶性疟原虫。令人鼓舞的是，我们加强了灭蚊措施，并增加了灭蚊用品的分发， 疟疾药物，如青蒿素类复方疗法，与减轻负担有关 疟疾在世界上许多地区的蔓延。然而，这些抗击疟疾的微弱进展不断地 由于抗药性蚊子的出现和青蒿素抗药性疟原虫的传播， 恶性疟原虫因此，人们普遍认为，加快疟疾控制和实现 根除疟疾的最终目标需要新的工具，包括高效疟疾疫苗， 抗疟疾药物和改进的蚊媒控制战略。为了成功应对这些挑战， 更清楚地了解疟原虫、其蚊媒和 需要它感染的脊椎动物宿主。2017年戈登疟疾研究会议（GRC）将重点关注 在疟原虫生命周期的每个阶段，疟原虫感染的基础生物学的进展。设置 作为一个发人深省的会议的阶段，该计划由疟疾和非疟疾科学家组成， 他们领域的前沿。该计划的目的是激发创新的想法和合作， 提供一个论坛，讨论最前沿的疟疾基础研究以及非疟疾领域的最新进展， 可能与疟疾有关的领域。会议之前将举行疟疾戈登研究 研讨会（GRS）从2017年7月1日至2日针对研究生，博士后和初级科学家。

Project Summary/Abstract 2017 Malaria Gordon Research Conference & Gordon Research Seminar The mosquito-transmitted Plasmodium parasites are responsible for approximately 200 million cases of malaria and 400,000 deaths annually worldwide, the vast majority of which are caused by Plasmodium falciparum. Encouragingly, the scale up of mosquito control measures and increased distribution of anti- malarial drugs, such as artemisinin-based combination therapy, have been associated with a reduced burden of malaria in many regions of the world. However, these tenuous gains against malaria are constantly threatened by the emergence of insecticide-resistant mosquitoes and the spread of artemisinin-resistant P. falciparum parasites. Consequently, there is broad consensus that accelerating malaria control and achieving the ultimate goal of malaria eradication will require new tools, including a highly effective malaria vaccine, new anti-malarial drugs and improved mosquito vector control strategies. To successfully meet these challenges, a clearer understanding of the complex interplay between the Plasmodium parasite, its mosquito vector and the vertebrate host it infects is needed. The 2017 Gordon Research Conference (GRC) on Malaria will focus on advances in the basic biology of Plasmodium infection at each stage of the parasite's life cycle. To set the stage for a thought-provoking meeting, the program is composed of both malaria and non-malaria scientists at the forefront of their fields. The aim of this program is to stimulate innovative ideas and collaborations by providing a forum to discuss cutting edge basic malaria research as well as recent advances in non-malaria fields with potential relevance to malaria. The conference will be preceded by the Malaria Gordon Research Seminar (GRS) from July 1-2, 2017 targeted at graduate students, post-docs and junior scientists.